trending Market Intelligence /marketintelligence/en/news-insights/trending/Qsjm0MqTt_q6feMQCDLSzw2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Shanghai Fosun completes stake acquisition in Indian generic maker

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Shanghai Fosun completes stake acquisition in Indian generic maker

Shanghai Fosun Pharmaceutical (Group) Co. Ltd. completed its acquisition of a 74% stake in Indian generic maker Gland Pharma Ltd.

Following completion of the $1.1 billion deal, Gland Pharma is now an indirect non-wholly owned subsidiary of Shanghai Fosun.